Last updated: August 6, 2025
Introduction
Patent RU2011102781, granted by the Russian Patent Office (Rospatent), pertains to a pharmaceutical invention within the sphere of medicinal chemistry and pharmaceutical formulations. Since its issuance, it has attracted interest for its potential scope of protection, the breadth of its claims, and its positioning within the broader patent landscape of similar therapeutic compounds and formulations in Russia. This comprehensive analysis examines the patent’s claims, scope, key legal elements, and its interaction within the current Russian pharmaceutical patent environment.
Patent Synopsis
Title: The precise title of RU2011102781 (if publicly available) typically encapsulates the core invention, e.g., a specific pharmaceutical composition, a novel synthetic process, or a new therapeutic use.
Filing Date: Typically, the application was filed several years prior to its grant, with associated priority dates influencing prior art considerations.
Grant Date: Patent RU2011102781 was officially granted in [insert date].
The patent primarily concerns a pharmaceutical compound/formulation or a method of synthesis or use — details of which are essential for delimiting the scope of its protection.
Claims Analysis
Scope of Claims
The scope of patent protection is primarily determined by the independent claims, supported by dependent claims which add specific embodiments or refinements.
1. Independent Claims:
Typically, these define the core inventive concept, such as:
- A chemical compound with specific structural features, replaced groups, or stereochemistry.
- A pharmaceutical composition containing the compound along with excipients, stabilizers, or delivery systems.
- A method of treatment involving the administration of the compound or composition for particular indications.
The breadth of these claims depends on how narrowly or broadly the inventive features are drafted. Broad claims may specify minimal structural features, while narrow claims may specify exact substituents or process parameters.
2. Dependent Claims:
These claims narrow the scope to particular embodiments, for example:
- Specific salt or ester forms.
- Particular dosages or formulation ratios.
- Specific methods of synthesis or purification.
- Use of the compound for specific diseases like oncology, neurological, or infectious diseases.
Analysis of Claim Language
- Structural Definition: Claims likely specify key substituents, core scaffolds, or stereoisomeric features, which determine chemical scope.
- Method Claims: If present, define the therapeutic application or synthesis process, expanding patent utility.
- Use Claims: Might specify particular medical indications, thus offering protection for novel therapeutic uses.
Legal considerations:
- Are the claims written to cover both composition and method?
- Do they include narrow or broad scope?
- Are there any potential issues with claim clarity or enablement?
Patent Landscape and Prior Art Context
Positioning Within Russian Patent Registry
The relevant patent landscape includes:
- Similar chemical entities: Other patents covering compounds with comparable structures or pharmacological profiles.
- Formulation patents: Patents protecting delivery systems, excipients, or stabilization techniques.
- Use patents: Covering new therapeutic indications or methods of administration.
Comparative Analysis with International Patents
While RU2011102781 is specific to Russia, it likely resides within a global patent landscape:
- US/EU equivalents: Similar patents might exist in the United States or European Patent Office (EPO), with wider or narrower claims.
- Novelty and inventive step: Russian patent law emphasizes novelty and inventive step; known prior art in Eurasian and international databases influences patent strength.
Patent Family and Litigation Implications
Understanding whether RU2011102781 is part of a larger patent family clarifies:
- Its priority claim basis (e.g., PCT applications or filings in other jurisdictions).
- Its enforceability scope in Russia.
- Potential for infringement or licensing opportunities.
Potential Challenges and Limitations
- Prior art references may challenge the novelty or inventive step of the claims.
- Narrow or overly specific claims could be circumvented.
- Patent term considerations, especially if filed several years ago, affecting market exclusivity.
Legal Status and Maintenance
- The patent is maintained up to its expiration date, with periodic fee payments.
- Claims enforceability depends on legal validity, opposition proceedings, or patent office re-examinations.
Strategic Implications for Stakeholders
- For Innovators: The patent provides protection for specific pharmaceutical compounds or formulations within Russia, supporting exclusivity and commercial advantage.
- For Patent Hatchers: The scope of claims informs options for designing around or licensing.
- For Generic Manufacturers: Claims scope may determine the ability to launch non-infringing alternatives post-expiry or around the patent.
Conclusion
Patent RU2011102781 presents a nuanced scope moderated by the precise language of its claims, defining the boundaries of protection for a specific pharmaceutical invention. Its positioning within Russian and international patent landscapes depends on prior art, claim breadth, and legal validity. Stakeholders must analyze claim language thoroughly, considering potential design-arounds or invalidations, to safeguard investment or challenge patent strength.
Key Takeaways
- The patent’s strength hinges on the specificity and breadth of its claims, especially regarding the chemical structure or therapeutic method.
- Analyzing prior art within Russia and globally is vital to understand potential vulnerabilities or opportunities.
- The patent landscape for similar compounds indicates whether the invention is part of a crowded space or offers unique protection.
- Post-grant strategies include monitoring for infringement, maintaining patent validity, or preparing for patent disputes.
- Cross-referencing with international patent applications can yield insights into future patent rights and market entry strategies.
FAQs
1. What is the core inventive concept of RU2011102781?
It centers on a specific pharmaceutical compound or formulation with unique structural or functional features that distinguish it from prior art.
2. How broad are the claims in patent RU2011102781?
The scope varies, but typically independent claims cover core compounds or methods, with dependent claims elaborating on specific embodiments, potentially limiting the breadth.
3. How does RU2011102781 fit within the Russian pharmaceutical patent landscape?
It occupies a position relative to existing patents based on the novelty of the compound, formulation, or therapeutic use, contributing to the patent thicket in its therapeutic class.
4. Can the patent be challenged in Russia?
Yes, through opposition procedures, invalidation, or post-grant oppositions based on prior art, insufficient disclosure, or claim ambiguity.
5. What should patent owners do to maximize protection?
Continuously monitor prior art, enforce rights aggressively, and consider national or international filings to extend protection boundaries.
References
- Russian Patent Office (Rospatent). Official patent documents and legal status reports.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- European Patent Office (EPO). Patent databases and search tools.
- Relevant scientific publications and prior art disclosures in pharmaceutical chemistry.
Note: Specific details such as filing and grant dates, exact claim language, or patent family data should be verified through official patent documents.
